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Exposure to ambient levels of particulate matter 
(PM) air pollution increases the risk of a host of 
cardiovascular diseases and events. One poten-
tial mechanism explaining this association is that 
acute exposure to PM at high concentrations is 
capable of raising blood pressure within hours 
to days. Epidemiologic studies confirm that even 
commonly encountered levels of airborne pol-
lutants can result in a prohypertensive response 
in humans. Several biologic pathways may be 
involved, including autonomic nervous system 
imbalance and arterial vascular dysfunction/
vasoconstriction due to systemic oxidative stress/
inflammation triggered by PM inhalation. The 
clinical importance of this vasopressor response 
and its relative role in promoting cardiovascu-
lar events associated with PM remain unclear. 
Because air pollution exposure is ubiquitous 
throughout the world, however, all health care 
providers and especially those who treat hyperten-
sion should be aware of this emerging and impor-
tant biologic relationship. (J Clin Hypertens. 
2007;9:629–635) ©2007 Le Jacq
Almost everyone is probably familiar with the pervasive gray-brown “haze” blanketing many 
modern cities and industrial regions. Fewer people 
are aware that this haze is typically transported 
hundreds of miles, making some level of airborne 
pollution virtually ubiquitous even in nonurban 
settings and natural environments.1 It has become 
so omnipresent in the past century as to be com-
monly perceived as a normal natural entity (eg, 
“the lazy, hazy days of summer”). We have learned 
to live in a soup of anthropogenic air pollutants 
without a second thought. Unfortunately, this haze 
is neither natural nor benign.1–4 The catastrophic 
pollution episodes in London and Belgium during 
the first half of the 20th century first brought to 
light its potential harmful effects.5,6 Subsequently, 
it was commonly believed that the more typically 
encountered pollution levels would be inconse-
quential to health.1,2 But just as it took longer to 
recognize the risks posed by passive exposure to 
tobacco smoke over and above those posed by 
active smoking7 (and even longer to do something 
about it), we have also learned that relatively low 
concentrations of air pollutants are harmful.3,4 
This brief review focuses on reasons for this to 
be of special interest to health care providers who 
treat hypertension.
AIR POLLUTION
Air pollution is a heterogeneous mixture of gases, 
liquids, and suspended particulate matter (PM).1 
PM itself is a complex amalgam of compounds 
varying in chemistry and ranging in size from sev-
eral nanometers to 10 μm in diameter. Particulate 
components and gaseous co-pollutants (eg, ozone, 
nitrogen dioxide) vary regionally and by their 
source. In the industrialized world, however, the 
majority of “fine PM” pollutants smaller than 
2.5 μm (PM2.5) are derived from the combustion 
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of fossil fuels (Figure 1).1,2 Most important from 
a health perspective, hundreds of constituents 
within PM2.5 possess a strong innate pro-oxidative 
potential and are thus able to impact biological 
organisms.1,4,8
Although various fractions have been associ-
ated with human illnesses, it is PM2.5 that is most 
strongly implicated as a possible cause of car-
diovascular (CV) diseases.3,4 Despite that levels 
have been reduced during the past 3 decades in 
the United States,1 present-day concentrations of 
PM2.5 still pose substantial health risks to the pub-
lic.3 Hundreds of epidemiologic studies throughout 
the world have demonstrated that current levels 
of ambient PM2.5 are associated with an increased 
risk of CV events. Both short- and long-term 
exposure to fine particles are associated with an 
increased risk of myocardial infarction, cardiac 
ischemia, heart failure, stroke, arrhythmias, exac-
erbations of peripheral arterial disease, hospital-
ization for CV conditions, and CV death.3,4 The 
acute risk to any single individual is relatively 
small. Because of the ubiquitous nature of constant 
involuntary exposure, however, outdoor air pol-
lution has been conservatively estimated to cause 
approximately 800,000 deaths per year worldwide 
(13th leading cause of mortality).9,10 Several recent 
reviews, including a statement from the American 
Heart Association,4 have summarized these data 
and highlighted the plausible biologic mechanisms 
capable of explaining this association (Figure 2).
Similar to air pollution, hypertension is an 
extremely prevalent problem. It also happens to be 
the single leading chronic cause of global mortal-
ity.10 Health care providers thus treat high blood 
pressure (BP) principally to reduce this risk of future 
CV events and death.11 As such, they should also be 
aware of the health risks posed by PM because it is 
another commonly encountered CV risk factor.11 
Additional findings have come to light that give fur-
ther reasons that hypertension experts in particular 
should care about air pollution.
AIR POLLUTION EXPOSURE AND BP
Animal and human exposure experiments, as well 
as epidemiologic studies, have demonstrated that 
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Figure 1. Sources and composition of particulate matter (PM) air pollution. Thoracic particles are all PM air pollut-
ants of a size <10 μg/m3, which are capable of being inhaled deeper into the lungs past the nasopharynx (ie, into the 
thorax). Coarse fraction particles encompass all thoracic particles that are larger than fine PM (ie, 2.5 – 10 μg/m3 in 
diameter). Fine particles are all thoracic PM <2.5 μg/m3; while ultrafine PM are those <0.1 μg/m3 in diameter. RBC 
indicates red blood cell; UFP, ultrafine particles; VOC, volatile organic carbons; SVOC, semi-VOC. 
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air pollutants are capable of raising BP.12 The 
literature linking adverse changes in hemodynam-
ics, endothelial function, arterial compliance, and 
autonomic activity with both active and passive 
tobacco smoke lends validity to the biologic plau-
sibility of this association.7 In a congruent fashion, 
other related atmospheric parameters such as high 
altitude, barometric pressure, and temperature are 
also known to impact BP.13 Thus, a link between 
PM exposure and BP changes is viable.14–25 This 
review will focus on the most pertinent previously 
discussed results12 (Table) along with newly avail-
able data.
Our randomized controlled experiments have 
shown that short-term exposure to high, yet rel-
evant, levels of concentrated ambient urban par-
ticles (150 μg/m3) significantly raise diastolic BP 
by 6 mm Hg (median increase) within minutes14 in 
healthy individuals without a history of hyperten-
sion. Follow-up analyses have demonstrated that 
the vasopressor response was related to the degree 
of organic carbon exposure (r=0.53; P=.009), which 
suggests that combustion sources (eg, automobiles) 
were responsible. Moreover, our ongoing studies 
continue to indicate a similar magnitude of acute 
prohypertensive responses within minutes to hours 
of controlled PM exposure (Bruce Urch, Gage 
Occupational and Environmental Health Unit, 
Toronto, Canada, oral communication, March 
2007). At present, it is not known whether persons 
with preexisting hypertension, smokers, or those 
with underlying CV conditions respond differently 
(eg, with exaggerated BP increases).
A few epidemiologic studies have demonstrated 
that the commonly encountered lower levels of 
ambient PM2.5 are also independently capable of 
elevating BP (Table). In Boston, cardiac rehabilita-
tion patients were found to have an increase in both 
systolic (2.8 mm Hg) and diastolic (2.7 mm Hg) 
BP, which correlated with the mean concentration 
of PM2.5 over the previous 5 days.
19 What was 
most striking is that this increase in BP occurred 
in response to very small changes in ambient air 
pollution (Δ10.5 μg/m3). Similar prohypertensive 
responses have been noted in Detroit among free-liv-
ing individuals. Comparably low levels of ambient 
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Figure 2. Mechanisms whereby particulate matter (PM) air pollution may cause cardiovascular events and hyperten-
sion. CRP indicates C-reactive protein; UFP, ultrafine particles; ROS, reactive oxygen species; WBC, white blood cells; 
NADPH, nicotinamide adenine dinucleotide phosphate (reduced) oxidase; SNS, sympathetic nervous system; AT2, angio-
tensin 2; ET, endothelins; IL, interleukin; TNF, tumor necrosis factor; CV cardiovascular; MI, myocardial infarction.
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urban PM2.5 raised BP by as much as 5.2 mm 
Hg systolic (J. Timothy Dvonch, School of Public 
Health, University of Michigan, oral communica-
tion, April 2007). As the BP increase was linearly 
related to the PM level, it is possible that on days 
with even higher PM elevations known to occur 
in Detroit and other urban cities (eg, >65 μg/m3), 
more marked vasopressor responses could occur. Of 
interest, air pollution raised BP only in certain city 
regions, which suggests that the chemical composi-
tion and constituents played a large role in deter-
mining the hemodynamic impact of exposure.
Several controlled experimental animal studies 
have also implicated PM exposure in BP elevation, 
although results have not been entirely consistent 
(Table). Recent studies show that high levels of 
PM2.5 can trigger a significant linear prohyper-
tensive response (+3.9/4.2 mm Hg) over 2 hours 
in dogs.26 Interestingly, α-adrenergic blockade 
mitigated the BP elevation. During hours 2 to 5 
of exposure, the BP elevation reached a plateau, 
while baroreceptor sensitivity was also shown to 
increase. The results suggest that the mechanism 
for BP increase may be principally related to 
peripheral vascular sympathetic stimulation, which 
is rapidly blunted by compensatory autonomic 
responses. In addition, it was recently shown that 
the vasopressor response to angiotensin II was 
significantly increased (Δ mean arterial pressure 
elevation of 57 vs 20 mm Hg) in Sprague-Dawley 
rats exposed to concentrated ambient PM2.5 com-
pared with filtered air.27 Vascular nicotinamide 
adenine dinucleotide phosphate (reduced) oxi-
dase and Rho-kinase–dependent pathways were 
found to be involved in the pathogenesis of the 
BP increase. These results suggest that individuals 
Table. Recent Studies Linking Particulate Matter (PM) Air Pollution With Blood Pressure (BP) Changes
HUMAN EXPOSURE STUDIES
Urch et al14 Significant (P=.017) median diastolic BP increase of 6 mm Hg within 2 hours during exposure to 
concentrated ambient fine PM from urban Toronto air plus ozone vs the impact of filtered air 
(crossover study) in 23 healthy adults. No significant change seen for systolic BP. 
Mills et al15 Borderline nonsignificant increases of 8 mm Hg (P=.13) for systolic and 6 mm Hg (P=.08) for 
diastolic BP in 15 subjects after exposure to diesel exhaust fumes for 1 hour compared with filtered 
air (crossover study).
Gong et al16 Systolic BP increased in 12 healthy participants exposed to concentrated ambient fine PM from 
urban Los Angeles for 2 hours vs filtered air (crossover study). No effect in asthmatic patients.
EPIDEMIOLOGIC STUDIES
Linn et al17 In 30 participants with lung disease, a 10-μg/m3 increase in PM was related to a 0.95-  
and 1.7-mm Hg increase in diastolic and systolic BP, respectively.
Ibald-Mulli et al18 In 2607 adults in Germany during an extreme air pollution episode of 1985, systolic BP was elevated 
by 1.79-mm Hg per 90 μg/m3 increase in total air particles. Systolic BP increased by ≈7 mm Hg 
in subgroups with elevated heart rates and plasma viscosity. Follow-up studies in 131 adults in a 
multicenter approach in Europe were not able to confirm BP elevations in relation to 24-hour mean 
PM levels.21
Zanobetti et al19 In 62 cardiac rehabilitation patients in Boston, BP was increased by 2.8/2.7-mm Hg per 10 μg/m3 
increase in PM2.5 during previous 5 days.
de Paula Santos et al20 In 48 healthy adults, interquartile ranges of ambient carbon monoxide and sulfur dioxide were 
significantly related to ambulatory BP increases of ≈2.5 mm Hg in São Paulo, Brazil. PM10 did not 
relate to BP.
Madsen and Nafstad34 In 18,770 Oslo citizens, there was no convincing association between BP and air pollution. In a 
subgroup of patients with prior heart disease and systolic BP >140 mm Hg, air pollution was 
associated with a higher BP.
Harrabi et al35 In 2612 elderly participants older than 65 years in France, PM10 was paradoxically associated with a 
small reduction in systolic BP.
ANIMAL EXPOSURE STUDIES
Wichers et al22 Direct bronchial instillation of the largest doses of PM in spontaneously hypertensive rats reduced 
cardiac output and BP. Limited study relevance to humans because of unrealistic dosing of PM.
Cheng et al23 Several days of intermittent exposure to concentrated ambient PM caused small BP reductions (mean 
arterial pressure decreased 3.3–4.1 mm Hg) in pulmonary hypertensive rats.
Chang et al24 Repeated exposure to concentrated ambient PM2.5 caused significant BP elevations of 8.7 mm Hg in 
the spring months. Summer month exposures yielded smaller effects.
Vincent et al25 Urban PM exposure caused a significant increase in BP that disappeared with washed PM, indicating 
that water-soluble (eg, metals) components of PM are responsible.
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with preexisting activation of the renin-angiotensin 
system (eg, some forms of primary and secondary 
hypertension) may be predisposed to a greater 
vasopressor response following PM exposure.
The overall evidence suggests that particulate 
air pollution is capable of meaningfully raising BP 
(≈2–10 mm Hg) in a dose-response fashion within 
hours to days in certain scenarios.12 Yet not all 
results have been positive.12,14 Unfortunately, only 
a few studies have specifically investigated the 
hemodynamic impact of PM exposure. Differences 
and null findings among the available studies are 
likely explained by differences in the multitude 
of variables that determine the responses. These 
include patient characteristics, animal models, dif-
ferential susceptibilities, BP measurement methods 
and accuracy, small BP changes and underpowered 
studies, missed transient effects, time courses of PM 
exposures and BP evaluations, variability in com-
pensatory hemodynamic reactions, PM concentra-
tions and composition, gaseous co-pollutants, PM 
sources, exposure mischaracterizations, and expo-
sure models. Further studies are warranted to help 
better our understanding of this complex relation-
ship. In particular, knowledge of the “responsible” 
pollution constituents/sources and identification 
of “at-risk” individuals are important. Perhaps 
even more important, the potential for long-term 
pollution exposure to promote the occurrence of 
chronic hypertension has yet to be reported. If such 
a positive biologic relationship occurs, it would 
have enormous public health implications.
POTENTIAL BIOLOGIC MECHANISMS
Several biologic mechanisms have been described 
whereby air pollution inhalation could trigger an 
elevation in BP (Figure 2).12 In brief, deposition of 
PM2.5 constituents deep within the pulmonary tree 
causes local tissue oxidative stress. The generation 
of oxidative species may be derived from chemicals 
within the particles (metals, semiquinones, organic 
carbon species) or from a subsequent cellular 
inflammatory response (activated macrophages, 
pulmonary cells). Variability in the PM compo-
sition, gaseous co-pollutants, and susceptibility 
(antioxidant defenses/enzymes) undoubtedly affect 
the degree of this response.1–4
The local pulmonary reaction is capable of 
affecting remote vascular sites, leading to a vaso-
pressor response by 3 general pathways.3,4,12 First, 
the particles may directly, or via the pulmonary 
oxidative stress/inflammation, stimulate a host of 
lung autonomic receptors. These airway receptors 
are capable of prompting rapid CV responses via 
neurally mediated reflexes. Activation of these 
pathways principally leads to systemic vagal with-
drawal, along with relative sympathetic hyperac-
tivity. Indeed, experiments have consistently shown 
reduced overall heart rate variability and, occasion-
ally, altered power spectral analyses, suggesting the 
triggering of cardiac autonomic imbalance favoring 
sympathetic tone following PM exposure.3,4 These 
autonomic responses could promote hypertension 
by a variety of means, including acute peripheral 
arterial vasoconstriction via α-adrenergic recep-
tors,26 increased cardiac heart rate/output, and in 
theory by chronically activating the renin-angio-
tensin system and blunting renal pressure nature-
sis. In addition, it has been experimentally shown 
that this autonomic imbalance can also cause oxi-
dative stress within the CV system by neurogenic 
sympathetic and parasympathetic receptor activa-
tion.28,29 This could subsequently lead to vascular 
dysfunction and arterial vasoconstriction.30
Second, numerous studies show that the oxida-
tive and inflammatory responses to PM are not iso-
lated to the lungs.3,4,28,29 Systemic and cardiac oxi-
dative stress, along with higher levels of circulating 
and vascular pro-inflammatory cells and cytokines, 
has been shown after PM inhalation.3,4 These fac-
tors are capable of instigating vascular endothelial 
dysfunction (eg, impaired nitric oxide bioavailabil-
ity) that could favor vasoconstriction.30 Indeed, 
endothelial dysfunction has been demonstrated 
in animals and humans exposed to air pollution 
both acutely and chronically.3,4,12,15,31,32 Moreover, 
the free radicals (eg, superoxide) could directly or 
indirectly trigger arterial vasoconstriction via the 
release of multiple vasoactive molecules (endo-
thelins, angiotensin II, asymmetric dimethylar-
ginine) shown to increase following PM inhala-
tion.12 Several human and animal studies have 
demonstrated systemic arterial vasoconstriction, 
impaired smooth muscle vasodilatory responses, 
and enhanced vasoconstrictor responsiveness after 
PM inhalation.3,4,12,15,31,32
Finally, many nanometer-sized particles or sol-
uble PM constituents could potentially be trans-
located into the systemic circulation and reach 
vascular beds following inhalation.3,4 This, how-
ever, is a controversial subject. The types of PM 
constituents capable of reaching the circulation 
(eg, size, chemistry, solubility), their levels in the 
blood and deposition in organs (eg, meaningful 
concentrations?), modes of transportation (eg, in 
plasma vs associated with lipoproteins or cells), 
and the remaining magnitude of oxidative activity 
reaching distal vascular sites all remain unknown. 
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Nevertheless, it is possible that CV tissue oxida-
tive stress could be generated by PM constituents 
reaching vascular sites.
In theory, the relative importance of the bio-
logic pathways in the etiology of the BP increase 
may vary with the time duration following expo-
sure. Autonomic imbalance and direct actions of 
blood-borne particle constituents may be princi-
pally responsible for BP changes within minutes, 
followed by the effects of systemic inflammation 
hours to days later. Further research will be 
required to better understand these issues and the 
overall mechanistic pathways involved.
CLINICAL IMPLICATIONS AND 
CONCLUSIONS
Although PM exposure can raise BP, the clinical 
impact of the relatively minor elevations remains 
unclear. The resultant overall health effect will 
likely vary depending on the susceptibility of the 
individual. In addition, the relative contribution 
that this vasopressor response plays in explain-
ing the multitude of observed adverse CV out-
comes caused by PM exposure is not known.3,4 
Nevertheless, similar prohypertensive responses 
are often hypothetically invoked as potential medi-
ators of the increased risk following several trig-
gering events (eg, sexual activity, mental stress, 
exercise, use of decongestant medications).33 It is 
possible that the BP increase per se and the accom-
panied increase in myocardial demand, in con-
junction with the underlying mechanisms respon-
sible for prompting them (autonomic imbalance, 
endothelial dysfunction, arterial vasoconstriction) 
might trigger plaque rupture and/or promote tissue 
ischemia. This might be observed as clinically overt 
events such as myocardial ischemia or stroke hours 
to days later. The hemodynamic changes and isch-
emia may also play some partial role in promoting 
the observed increase in heart failure and arrhyth-
mias. Finally, it is plausible that intermittent long-
term air pollution exposure could continue to pro-
mote BP increases or cause underlying autonomic 
and vascular changes known to be causal in the 
etiology of primary hypertension. Thus, sustained 
exposure to higher levels of PM may contribute to 
the genesis of chronic hypertension.
In summary, the available evidence suggests that 
PM air pollution exposure is capable of raising 
BP over hours to days by a clinically meaningful 
magnitude in some situations. Nevertheless, many 
issues remain to be fully elucidated. Foremost is 
to determine whether long-term exposure actu-
ally promotes chronic hypertension and whether 
reductions in air pollution lead to decreases in BP. 
In other words, is air pollution a “modifiable” 
environmental risk factor for hypertension? Future 
research can help further our understanding of this 
important public health issue.
Addendum: A recent study demonstrated in Guatemalan 
women that chronic exposure to fine particulate wood smoke 
pollution was independently linked to higher blood pressures 
and that lowering exposure levels was associated with a signifi-
cant reduction in blood pressure of 3.7/3.0 mm Hg.36
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